alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
400 MARYLAND AVE. S.W., WASHINGTON, DC 20202-2600

www.ed.gov

The Department of Education’s mission is to promote student achievement and preparation for global competitiveness

by fostering educational excellence and ensuring equal access.

UNITED STATES DEPARTMENT OF EDUCATION 

OFFICE OF SPECIAL EDUCATION AND REHABILITATIVE SERVICES 

October 1, 2020 

Honorable Dr. Matthew L. Blomstedt 

Commissioner of Education 

Nebraska Department of Education 

301 Centennial Mall South 

P.O. Box 94987 

Lincoln, Nebraska 68509 

matt.blomstedt@nebraska.gov

Dear Commissioner Blomstedt: 

This letter grants final approval under Section 421(b) of the General Education Provisions Act 

for grant award H181A180033. 

The Department received your September 17, 2020 request on behalf of the Nebraska 

Department of Education for a waiver extending the period of availability for Federal fiscal year 

(FFY) 2018 Individuals with Disabilities Education Act (IDEA) Part C grant award funds. 

With this approval, the FFY 2018 IDEA Part C grant award funds will be available for obligation 

through September 30, 2021 and may be liquidated through December 30, 2021. 

Please contact your Office of Special Education Programs (OSEP) State lead, Tony Williams at 

TonyG.Williams@ed.gov, if you have any questions. 

Sincerely,

/s/

Mark Schultz 

Commissioner, Rehabilitation Services Administration

Delegated the authority to perform the functions and duties of the 

Assistant Secretary for the Office of Special Education and 

Rehabilitative Services

cc: Part C Coordinator
Office for Civil Rights - OPEN Center - Organizational Structure – 8/28/2022 

Graphic Version

(An accessible text version can be found on the following page.)
Accessible Text Version

Office for Civil Rights (OCR) -OPEN Center - Organizational Structure

• Deputy Assistant Secretary for Strategic Operations and Outreach

• OPEN Director

• Public Information Team

• OPEN Deputy Director

• Attorney Advisor, Public Information Team

• Government Information Specialist (Team Lead), Public Information Team

• Government Information Specialist, Public Information Team – six total

• Customer Service Team

• OPEN Deputy Director 

• Attorney Advisor, Customer Service Team – two total

• General Attorney, Customer Service Team – two total

• Management and Program Analyst, Customer Service Team – three total

• Immediate Office

• Management Analyst, Immediate Office

• Attorney Advisor, Immediate Office – two total
United States Court of Appeals,

Eleventh Circuit.

No. 94-5181.

Carol MIRE, Plaintiff-Appellant,

v.

BLUE CROSS/BLUE SHIELD OF FLORIDA, Defendant-Appellee.

Dec. 9, 1994.

Appeal from the United States District Court for the Southern

District of Florida. (No. 94-6851-CIV-WJZ), William J. Zloch,

Judge.

Before HATCHETT and ANDERSON, Circuit Judges, and FAY, Senior

Circuit Judge.

PER CURIAM:

This case has been expedited because of the serious medical

condition of the appellant and the urgent need for a speedy

resolution. Appellant, Carol Mire, has and is being treated for

ovarian cancer. The question before us is whether or not a

specific treatment is covered or excluded by health insurance

provided to her through her husband's employment.

The treatment and subsequent hospitalization involved in the

recommended HDC/PSCR is described by appellant as:

1. induction phase or chemotherapeutic agents administered in

low doses;

2. mobilization phase which consists of chemotherapeutic

agents administered in intermediate doses;

3. leukapheresis, the removal of the stem cells which are

subsequently frozen and stored;

4. HDC which consists of the administration of FDA approved

chemotherapeutic agents in high doses;

5. the reinfusion of the stored stem cells into the patient's

body;
6. hospitalization for observation purposes.

The Blue Cross policy involved contains the following

exclusion:

The following services, supplies or equipment are not Covered

Services under this Contract, and, therefore, BCBSF has no

liability for such services, supplies or equipment. The

insured is solely responsible for the payment of charges for

all services or supplies excluded in this Section.

 . . . . .

32. Any service or supply relating to any evaluation,

treatment or therapy involving the use of high-dose

chemotherapy and adjuvant autologous bone marrow transplant,

autologous peripheral stem cell rescue, or autologous stem

cell rescue for any disease other than acute lymphocytic

leukemia, acute non-lymphocytic leukemia, Hodgkins' disease,

non-Hodgkins' lymphoma, neuroblastoma, breast cancer or

germ-cell malignancies.

It is Mire's contention that while the above clause excludes

any and all treatment, services and supplies related to HDC and

PSCR, it does not include the HDC and PSCR treatment itself. We

are simply unable to agree.

We conclude that the plain meaning of the exclusion eliminates

coverage for this suggested treatment for appellant's non-germ cell

ovarian cancer.

The judgment of the district court is AFFIRMED.
2009.570-5 Contract clauses. ( a ) *General contract clause.* All contracts and simplified acquisitions of the types set forth in 2009.570-4(b) must include the clause entitled, “Contractor Organizational Conflicts of Interest,” set forth in 2052.209-72.
( b ) *Other special contract clauses.* If it is determined from the nature of the proposed contract that an organizational conflict of interest exists, the contracting officer may determine that the conflict can be avoided, or, after obtaining a waiver in accordance with 2009.570-9, neutralized through the use of an appropriate special contract clause. If appropriate, the offeror may negotiate the terms and conditions of these clauses, including the extent and time period of any restriction. These clauses include but are not limited to: ( 1 ) Hardware exclusion clauses which prohibit the acceptance of production contracts following a related non-production contract previously performed by the contractor;
( 2 ) Software exclusion clauses;
( 3 ) Clauses which require the contractor (and certain of its key personnel) to avoid certain organizational conflicts of interest; and
( 4 ) Clauses which provide for protection of confidential data and guard against its unauthorized use.
CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350





In connection with the accompanying Quarterly Report on Form 10-Q of Cagles, Inc. for the period ended October 1, 2005 as filed with the Securities and Exchange Commission on the date hereof (the Form 10-Q), I, Mark M. Ham IV, Chief Financial Officer of Cagles, Inc., certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:



1. The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934, and



2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: November 9, 2005

By: /s/ Mark M. Ham IV

Mark M. Ham IV

Chief Financial Officer
Case: 3:12-cr-50027 Document #: 220 Filed: 02/09/15 Page 1 of 3 PageID #:1268
Case: 3:12-cr-50027 Document #: 220 Filed: 02/09/15 Page 2 of 3 PageID #:1269
Case: 3:12-cr-50027 Document #: 220 Filed: 02/09/15 Page 3 of 3 PageID #:1270
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 1 of 9 PageID #:141
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 2 of 9 PageID #:142
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 3 of 9 PageID #:143
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 4 of 9 PageID #:144
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 5 of 9 PageID #:145
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 6 of 9 PageID #:146
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 7 of 9 PageID #:147
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 8 of 9 PageID #:148
Case: 1:12-cv-03423 Document #: 23 Filed: 12/27/12 Page 9 of 9 PageID #:149
```

                                                                 EXHIBIT 10.15.1

Schedule of Omitted Documents in the Form of Exhibit 10.15, Including Material
Detail in Which Such Documents Differ from Exhibit 10.15

1.   Stock Option Agreement, dated as of July 29, 2004, between the Company and
     John F. McCarthy, III (20,000 shares).

2.   Stock Option Agreement, dated as of July 29, 2004, between the Company and
     John F. McCarthy, III (25,000 shares).

3.   Stock Option Agreement, dated as of July 29, 2004, between the Company and
     Robert H. Donehew (20,000 shares).

4.   Stock Option Agreement, dated as of July 29, 2004, between the Company and
     Robert H. Donehew (75,000 shares).

5.   Stock Option Agreement, dated July 29, 2004, between the Company and
     Anthony Charos (20,000 shares).

         The form of the documents listed above does not differ in material
detail from the form of exhibit 10.15 except with respect to the identity of the
director and the number of shares of common stock underlying the options.
```
(October 17, 1963)

#### The People of the State of New York, Respondent, *v.*Diego Lopez, Appellant.

*Per Curiam.*

Defendant appeals from a conviction of criminally carrying a concealed weapon, as an attempt (Penal Law, §§ 2, 1897, subd. 5-a), upon his plea of guilty. The plea followed a denial, after a hearing, of a motion to suppress evidence.

The issue presented on the motion was purely factual and the evidence was clearly sufficient to sustain the conclusion that the arresting officer saw the *810outline of a revolver in defendant’s .pocket and was warranted in the belief that defendant was carrying a concealed weapon, as he, in fact, was.

The only question' on this appeal arises from the fact that the court, in denying the application, made no findings. The Second Department has directed that on every such motion the court should indicate by opinion or findings the facts on which he relies in reaching his conclusion *(People*v. *Lombardi,*18 A D 2d 177). We ¡believe this to be a sound practice and it should be followed on future applications.

In the instant case the record satisfactorily indicates the conclusions reached by the court and, as these are so amply supported in the evidence, we find that no useful purpose would be served by a remand for findings.

The judgment of conviction should be affirmed.

Breitel, J. P., McNally, Stevens, Eager and Steuer, JJ., concur.

Judgment of conviction unanimously affirmed.
Certifications:

I, Joseph F. Kruy, certify that:

1. I have reviewed this quarterly report on Form 10QSB of Cambex Corporation;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this quarterly report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
particularly during the period in which this quarterly report is being
prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and

c) presented in this quarterly report our conclusions about the effectiveness
of the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the
equivalent functions):

a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls;
and

6. The registrant's other certifying officers and I have indicated in this
quarterly report whether there were significant changes in internal controls
or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any
corrective actions with regard to significant deficiencies and material
weaknesses.

Date: August 11, 2006

/s/ Joseph F. Kruy
Joseph F. Kruy
President and Treasurer
(principal executive officer and principal financial officer)
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

# TIME AND DATE: 

2:00 p.m. on Wednesday, January 27, 2021.

# PLACE: 

The meeting will be held via remote means and/or at the Commission's headquarters, 100 F Street NE, Washington, DC 20549.

# STATUS: 

This meeting will be closed to the public.

# MATTERS TO BE CONSIDERED: 

Commissioners, Counsel to the Commissioners, the Secretary to the Commission, and recording secretaries will attend the closed meeting. Certain staff members who have an interest in the matters also may be present.

                        In the event that the time, date, or location of this meeting changes, an announcement of the change, along with the new time, date, and/or place of the meeting will be posted on the Commission's website at                         *https://www.sec.gov.*

The General Counsel of the Commission, or his designee, has certified that, in his opinion, one or more of the exemptions set forth in 5 U.S.C. 552b(c)(3), (5), (6), (7), (8), 9(B) and (10) and 17 CFR 200.402(a)(3), (a)(5), (a)(6), (a)(7), (a)(8), (a)(9)(ii) and (a)(10), permit consideration of the scheduled matters at the closed meeting.

The subject matter of the closed meeting will consist of the following topics:

Institution and settlement of injunctive actions;

Institution and settlement of administrative proceedings;

Resolution of litigation claims; and

Other matters relating to enforcement proceedings.

At times, changes in Commission priorities require alterations in the scheduling of meeting agenda items that may consist of adjudicatory, examination, litigation, or regulatory matters.

# CONTACT PERSON FOR MORE INFORMATION: 

For further information; please contact Vanessa A. Countryman from the Office of the Secretary at (202) 551-5400.

Dated: January 19, 2021.

Vanessa A. Countryman,

Secretary.

[FR Doc. 2021-01530 Filed 1-19-21; 4:15 pm]

BILLING CODE 8011-01-P
1506.303-2 Content. The documentation requirements in this section apply only to acquisitions processed using other than small purchase procedures. (Refer to 1513.170 for documentation for small purchase acquisitions). ( a ) The initiating office shall prepare a written justification for other than full and open competition (JOFOC) that documents the facts and circumstances substantiating the infeasibility of full and open competition for each recommended limited sources or sole source acquisition when required by FAR 6.302.
( b ) The recommendation shall be entitled “Justification for Other Than Full and Open Competition” and shall be signed at the programmatic Division Director or comparable office level prior to submission with the procurement request. The JOFOC shall contain the information prescribed in FAR 6.303-2 (a) and (b).
( c ) If unusual and compelling urgency (see FAR 6.303-2) is a basis for the JOFOC, then the following applies. Explain the circumstances that led to the need for an urgent contractual action. Explain why the requirement could not have been processed in sufficient time to permit full and open competition. It should be noted that the existence of legislation, court order, or Presidential mandate is not, of itself, a sufficient basis for a JOFOC. However, the circumstances necessitating legislation, court order, or Presidential mandate may justify contractual action on an other than full and open competition basis.
( d ) If the proposed acquisition has been synopsized in accordance with the applicable requirements in FAR subpart 5.2, the Contracting Officer must incorporate the evaluation of responses to the synopsis in the JOFOC. (See 1506.371(d) for contents of the evaluation document).
[50 FR 14357, Apr. 11, 1985; 50 FR 15425, Apr. 18, 1985]
225.7004-2 Restrictions. Except as provided in 225.7004-3, do not acquire any of the following items, either as end products or components, unless the manufacturer of the items is part of the national technology and industrial base: ( a ) Buses, if multipassenger motor vehicles are purchased, leased, rented, or made available under contracts for transportation services.
( b ) Components for naval vessels, to the extent they are unique to marine applications (see also 225.7004-4 for implementation of the restriction for naval vessels): ( 1 ) Gyrocompasses.
( 2 ) Electronic navigation chart systems.
( 3 ) Steering controls.
( 4 ) Propulsion and machinery control systems.
( 5 ) Totally enclosed lifeboats.
( 6 ) Welded shipboard anchor and mooring chain. See also 225.7004-5.
( c ) Large medium-speed diesel engines for new construction of auxiliary ships using funds available for National Defense Sealift Fund programs or Shipbuilding and Conversion, Navy.
( d ) For T-AO 205 and T-ARC class vessels: ( 1 ) Auxiliary equipment, including pumps, for all shipboard services.
( 2 ) Propulsion system components, including engines, reduction gears, and propellers.
( 3 ) Shipboard cranes.
( 4 ) Spreaders for shipboard cranes.
( e ) Star trackers.
[89 FR 46813, May 30, 2024]
| (1) | The      Report fully complies with the requirements of Section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|-----|--------------------------------------------------------------------------------------------------------------------------------|

| (2) | The      information contained in this Report fairly presents, in all material      respects, the financial condition and results of operations of the      Registrant. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Dated      this 13th      day of September, 2010 | By:      /s/ Xiao Ping Zhang |
|--------------------------------------------------|------------------------------|
|                                             | Xiao      Ping Zhang         |
|                                             | Chief      Executive Officer |
|                                             |                         |
|                                             | By:      /s/ Zong Yun Zhou   |
|                                             | Zong      Yun Zhou           |
|                                             | Chief      Financial Officer |

----
<TABLE> <S> <C>

<PAGE>
<ARTICLE> UT
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 
CONSOLIDATED FINANCIAL STATEMENTS OF CASCADE NATURAL GAS CORPORATION INCLUDED
IN THE QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 1998 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               JUN-30-1998
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                      274,412
<OTHER-PROPERTY-AND-INVEST>                      1,841
<TOTAL-CURRENT-ASSETS>                          26,054
<TOTAL-DEFERRED-CHARGES>                        10,317
<OTHER-ASSETS>                                       0
<TOTAL-ASSETS>                                 312,624
<COMMON>                                        11,045
<CAPITAL-SURPLUS-PAID-IN>                       97,381
<RETAINED-EARNINGS>                              7,621
<TOTAL-COMMON-STOCKHOLDERS-EQ>                 116,047
<PREFERRED-MANDATORY>                            6,408
<PREFERRED>                                          0
<LONG-TERM-DEBT-NET>                           110,650
<SHORT-TERM-NOTES>                               4,482
<LONG-TERM-NOTES-PAYABLE>                            0
<COMMERCIAL-PAPER-OBLIGATIONS>                       0
<LONG-TERM-DEBT-CURRENT-PORT>                   10,000
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                          0
<LEASES-CURRENT>                                     0
<OTHER-ITEMS-CAPITAL-AND-LIAB>                  65,037
<TOT-CAPITALIZATION-AND-LIAB>                  312,624
<GROSS-OPERATING-REVENUE>                      163,527
<INCOME-TAX-EXPENSE>                             6,852
<OTHER-OPERATING-EXPENSES>                     137,988
<TOTAL-OPERATING-EXPENSES>                     137,988
<OPERATING-INCOME-LOSS>                         25,539
<OTHER-INCOME-NET>                                 322
<INCOME-BEFORE-INTEREST-EXPEN>                  19,009
<TOTAL-INTEREST-EXPENSE>                         7,621
<NET-INCOME>                                    11,388
<PREFERRED-STOCK-DIVIDENDS>                        373
<EARNINGS-AVAILABLE-FOR-COMM>                   11,015
<COMMON-STOCK-DIVIDENDS>                         7,947
<TOTAL-INTEREST-ON-BONDS>                            0
<CASH-FLOW-OPERATIONS>                          34,851
<EPS-PRIMARY>                                     1.00
<EPS-DILUTED>                                     1.00
        

</TABLE>